BMY vs COMP · P/E 17, rev $48.19B vs rev $5.63B
Bristol-Myers Squibb Company (BMY) versus Compass Inc (COMP) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Compass Inc (COMP) is a real estate services company listed on US.
Latest reported BMY revenue for 2025-12-31 was $48.19B. Net income was $7.05B. Revenue was down 0.2% from 2024-12-31 to 2025-12-31. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported COMP revenue for 2024-12-31 was $5.63B. Net income was -$154.5M. Revenue was up 15.2% from 2023-12-31 to 2024-12-31. COMP currently screens at market cap $3.35B.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. COMP currently screens at market cap $3.35B.
Not investment advice. Open the BMY and COMP stock pages for the full models.
Not investment advice.